Author(s): Van den Eynde BJ, van der Bruggen P
Abstract Share this page
Abstract T cell defined antigens have now been characterized in a large variety of tumor types, in both mice and humans. An increasing number of these antigens appear to result from tumor-specific mutations, and some of these mutations may be implicated in oncogenesis. The priority is now to demonstrate that immunization against some of these antigens is clinically valuable for antitumor therapy, and the first results of clinical pilot studies are now emerging.
This article was published in Curr Opin Immunol
and referenced in Journal of Clinical & Cellular Immunology